Southwest Oncology Group

西南肿瘤组

• 批准号: 8073085
• 负责人: JONATHAN W FRIEDBERG
• 金额: $ 35.57万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-06-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8073085
• 关键词: Adult; Advanced Malignant Neoplasm; Basic Science; Cancer Biology; Cancer Center; Cancer Control; Cancer Hospital; Cancer Patient; Caring; Clinical; Clinical Trials; Country; Data Collection; Development; Disease; Education; Enrollment; Faculty; Goals; Health; Hospitals; Information Dissemination; Investments; Laboratory Research; Malignant - descriptor; Malignant Neoplasms; Massachusetts; Methodology; Modality; New York; Patient Care; Patients; Phase; Population; Prevention; Protocols documentation; Publications; Recruitment Activity; Research Institute; Site; Southwest Oncology Group; Supportive care; Therapeutic; Translational Research; Universities; cancer prevention; cancer therapy; improved; innovation; member; multidisciplinary; multimodality; novel strategies; outreach; programs; tertiary care

DESCRIPTION (provided by applicant): The University of Rochester is a health and research institute ideally suited to help achieve the goals of the Southwest Oncology Group (SWOG). These goals include: improve standards of care to adult cancer patients advance the understanding of cancer biology via translational research, promote treatment and supportive care to outreach sites through NCI-supported clinical trial participation, explore innovative multi-modality treatment combinations, support cancer prevention efforts, and refine methodology of clinical cancer trials. Our activity (2002 -to date) as fiinded members of the Southwest Oncology Group, indicates our continuous investment in and commitment to clinical and basic laboratory research, patient care, and education. To date we have enrolled 762 cases and served as study chair or co-chair of 14 SWOG protocols; 27 multidisciplinary members actively participated in one or more committees (seven faculty members served as chair and/or co-chair of 21 committees). Eleven faculty members coordinated or co-coordinated 20 protocols and 2studies currently in development. As we recruit more clinical-scientific faculty and further develop interactive, collaborative, multimodality cancer programs, we plan to produce additional important contributions to SWOG. The University of Rochester SWOG program involves 1) The University's James P. Wilmot Cancer Center and the University's Strong Memorial Hospital, a primary tertiary care center. The Cancer Center and hospital serves a population of approximately 1.4 million people 2) Six outreach facilities located In the regronal Northeast section of the country (contiguous states of New York and Massachusetts) Through this Southwest Oncology Group apphcation, our program continues to support and attain objectives to 1) participatein multi-modal Phase II/III clinical trials, 2) accelerate the advances of cancer therapy in adult patients through increased recruitment, 3) enhance basic science clinical interactions; 4) support cancer control and prevention initiatives, 5) provide wide dissemination of information through quality and timely data collection and publications, 6) continueservice to the administrative agenda of the Southwest Oncology Group.

描述（由申请人提供）： 罗切斯特大学是一个健康和研究机构，非常适合帮助实现西南肿瘤学小组（SWOG）的目标。这些目标包括：提高成人癌症患者的护理标准，通过转化研究促进对癌症生物学的理解，通过参与国家癌症研究所支持的临床试验促进治疗和支持性护理，探索创新的多模式治疗组合，支持癌症预防工作，并改进临床癌症试验的方法。我们的活动（2002年至今）作为西南肿瘤组的finded成员，表明我们在临床和基础实验室研究，病人护理和教育的持续投资和承诺。到目前为止，我们已经招募了762例，并担任研究主席或14 SWOG协议的联合主席; 27个多学科成员积极参加了一个或多个委员会（7名教师担任主席和/或21个委员会的联合主席）。11名教员协调或共同协调了20项协议和20项研究，目前正在开发中。随着我们招募更多的临床科学教师，并进一步发展互动，协作，多模态癌症计划，我们计划产生额外的重要贡献SWOG。罗切斯特大学SWOG项目包括：1）大学的詹姆斯·P·威尔莫特癌症中心和大学的斯特朗纪念医院，一个初级三级保健中心。癌症中心和医院为大约140万人提供服务2）位于该国东北部地区（纽约和马萨诸塞州的毗连州）的六个外展设施 通过这次西南肿瘤组的申请，我们的项目继续支持并实现以下目标：1）参与多模式II/III期临床试验，2）通过增加招募加速成人患者癌症治疗的进展，3）加强基础科学临床互动; 4）支持癌症控制和预防倡议，5）通过高质量和及时的数据收集和出版物广泛传播信息，6）继续服务于西南肿瘤组的行政议程。